Literature DB >> 19555761

P90 Ribosomal s6 kinase 2 negatively regulates axon growth in motoneurons.

Matthias Fischer1, Patricia Marques Pereira, Bettina Holtmann, Christian M Simon, Andre Hanauer, Martin Heisenberg, Michael Sendtner.   

Abstract

Mutations in Ribosomal s6 kinase 2 (Rsk2) are associated with severe neuronal dysfunction in Coffin-Lowry syndrome (CLS) patients, flies and mice. So far, the mechanisms of how Rsk2 regulates development, maintenance and activity of neurons are not understood. We have investigated the consequences of Rsk2 deficiency in mouse spinal motoneurons. Survival of isolated Rsk2 deficient motoneurons is not reduced, but these cells grow significantly longer neurites. Conversely, overexpression of a constitutively active form of Rsk2 leads to reduced axon growth. Increased axon growth in Rsk2 deficient neurons was accompanied by higher Erk 1/2 phosphorylation, and the knockout phenotype could be rescued by pharmacological inhibition of MAPK/Erk kinase (Mek). These data indicate that Rsk2 negatively regulates axon elongation via the MAPK pathway. Thus, the functional defects observed in the nervous system of CLS patients and animal models with Rsk2 deficiency might be caused by dysregulated neurite growth rather than primary neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555761     DOI: 10.1016/j.mcn.2009.06.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  8 in total

1.  The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury.

Authors:  Hassan Al-Ali; Ying Ding; Tatiana Slepak; Wei Wu; Yan Sun; Yania Martinez; Xiao-Ming Xu; Vance P Lemmon; John L Bixby
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

2.  Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.

Authors:  Sunny Hartwig; Jacqueline Ho; Priyanka Pandey; Kenzie Macisaac; Mary Taglienti; Michael Xiang; Gil Alterovitz; Marco Ramoni; Ernest Fraenkel; Jordan A Kreidberg
Journal:  Development       Date:  2010-04       Impact factor: 6.868

3.  Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.

Authors:  Hassan Al-Ali; Do-Hun Lee; Matt C Danzi; Houssam Nassif; Prson Gautam; Krister Wennerberg; Bill Zuercher; David H Drewry; Jae K Lee; Vance P Lemmon; John L Bixby
Journal:  ACS Chem Biol       Date:  2015-06-24       Impact factor: 5.100

4.  RSK1 promotes mammalian axon regeneration by inducing the synthesis of regeneration-related proteins.

Authors:  Susu Mao; Yuanyuan Chen; Wei Feng; Songlin Zhou; Chunyi Jiang; Junjie Zhang; Xiaohong Liu; Tianmei Qian; Kai Liu; Yaxian Wang; Chun Yao; Xiaosong Gu; Bin Yu
Journal:  PLoS Biol       Date:  2022-06-01       Impact factor: 9.593

5.  Chemical interrogation of the neuronal kinome using a primary cell-based screening assay.

Authors:  Hassan Al-Ali; Stephan C Schürer; Vance P Lemmon; John L Bixby
Journal:  ACS Chem Biol       Date:  2013-03-19       Impact factor: 5.100

Review 6.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

7.  Loss of the Coffin-Lowry syndrome-associated gene RSK2 alters ERK activity, synaptic function and axonal transport in Drosophila motoneurons.

Authors:  Katherina Beck; Nadine Ehmann; Till F M Andlauer; Dmitrij Ljaschenko; Katrin Strecker; Matthias Fischer; Robert J Kittel; Thomas Raabe
Journal:  Dis Model Mech       Date:  2015-09-03       Impact factor: 5.758

Review 8.  Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction.

Authors:  Matthias Fischer; Thomas Raabe
Journal:  Front Behav Neurosci       Date:  2018-05-23       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.